Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
succinate dehydrogenase complex iron sulfur subunit B | 0.474 | 0.846 | 2.4E-04 |
|
group | 0.110 | None | 1.000 | 127 | 71 | 1995 | 2018 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.500 | None | 1.000 | 127 | 23 | 1992 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 127 | 17 | 2002 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 1.000 | 126 | 3 | 2000 | 2020 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 126 | 1 | 2004 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 125 | 2 | 2005 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 125 | 0 | 1996 | 2019 | ||||||||
|
F-box protein 11 | 0.604 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 125 | 273 | 1991 | 2017 | ||||||||
|
glutaryl-CoA dehydrogenase | 0.691 | 0.385 | 4.9E-03 |
|
disease | 1.000 | definitive | 1.000 | 123 | 111 | 1988 | 2020 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
disease | 0.100 | None | 1.000 | 123 | 0 | 2002 | 2020 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.900 | None | 1.000 | 123 | 54 | 1976 | 2016 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
group | 0.100 | None | 1.000 | 123 | 83 | 2001 | 2017 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.400 | None | 1.000 | 123 | 0 | 1987 | 2020 | ||||||||
|
POU class 5 homeobox 1 pseudogene 4 | 0.452 | 0.808 |
|
group | 0.100 | None | 1.000 | 122 | 0 | 2003 | 2020 | |||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 121 | 1 | 2008 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 120 | 0 | 1990 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.500 | None | 1.000 | 120 | 2 | 1998 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.200 | None | 1.000 | 120 | 2 | 1994 | 2019 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 1.000 | None | 1.000 | 119 | 106 | 1993 | 2019 | ||||||||
|
gap junction protein beta 1 | 0.514 | 0.731 | 0.85 |
|
disease | 1.000 | None | 1.000 | 119 | 82 | 1993 | 2019 | ||||||||
|
alkaline phosphatase, biomineralization associated | 0.546 | 0.769 | 3.6E-04 |
|
disease | 0.700 | strong | 1.000 | 119 | 23 | 1992 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 118 | 0 | 2012 | 2020 | ||||||||
|
myosin binding protein C3 | 0.593 | 0.385 | 8.0E-11 |
|
disease | 0.900 | definitive | 1.000 | 118 | 143 | 1990 | 2019 | ||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.100 | None | 1.000 | 118 | 0 | 1990 | 2019 | |||||||||
|
POU class 5 homeobox 1 pseudogene 4 | 0.452 | 0.808 |
|
group | 0.100 | None | 1.000 | 117 | 0 | 2003 | 2020 |